Experts from China, the United States and Europe jointly explored the construction of non-public ophthalmology medical t
Experts from China, the United States and Europe jointly explored the construction of non-public ophthalmology medical teaching and research system
September 15, 2017
At the 22nd National Conference of Ophthalmology of the Chinese Medical Association
Ophthalmology experts and scholars from China, the United States and Europe gathered together to discuss the construction of non-public ophthalmology medical teaching and research system.
With the support of national policies, non-public hospitals have developed rapidly and their service capabilities have been continuously improved.
So how to build and improve the medical teaching and research system of non-public hospitals?
How can its soft power be improved? In this regard, the experts launched an in-depth dialogue and heated discussion.
The future of ophthalmology in China lies in the progress of medical institutions, ophthalmologists and scholars.
Historic reform and innovation will be ushered in! Aier Ophthalmology, the world's largest ophthalmology hospital group, shoulders the burden of the well-being of eye disease patients in China and even in the world
Forging ahead.
The dialogue was chaired by Professor Tang Shibo, President of Aier Eye Hospital Group, Dean of Aier Eye School of Central South University, and Director of Aier Eye Institute.
Professor Wang Mingxu, CEO of Aier Ophthalmology USA, Professor Peng Zhipei, Chinese University of Hong Kong and Shantou International Eye Center,
Professor Wang Ningli, President of Beijing Tongren Hospital Affiliated to Capital Medical University, Former Chairman of the Ophthalmology Branch of the Chinese Medical Association, President of the Ophthalmology Branch of the Chinese Medical Doctor Association, and Chairman of the Asia-Pacific Ophthalmological Society
Professor Sun Xinghuai, President-elect of the Ophthalmology Branch of the Chinese Medical Association, and Dr. Toam Katz, Medical Director of Aier Ophthalmology Germany
Professor Lin Ding, doctoral supervisor of Aier School of Ophthalmology, Central South University, general dean of Aier Ophthalmology in Hunan Province, and leader of the glaucoma group of the group
Chen Bang, chairman of Aier Ophthalmology Group, made a passionate dialogue,
The sagacity of words shines with the brilliance of thought.
Tang Shibo (President of Aier Eye Hospital Group) "Over the years,
Science, education and research are more concentrated in public hospitals, university systems, however,
Today, non-public medical institutions have achieved a place in the field of scientific research and academics. ”
Wang Mingxu (CEO of Aier Ophthalmology USA) "In the United States, the four best eye hospitals,
It is all a private eye hospital.
More than half of the best doctors are in private eye hospitals.
Aier Ophthalmology has played a leading role in the development of ophthalmology in China.
The example of the United States proves that non-public eye hospitals can also do world-class scientific research.
Guide the direction of ophthalmology development in the whole country.
Recommended Reading:
False eye care knowledge is made public by Pang Zhipei (Chinese University of Hong Kong) "In Hong Kong,
All professors and doctors who participate in research and participate in academic work have only one salary
In addition, there may be some subsidies.
The value of the research itself and the pleasant working atmosphere attract doctors, professors and research teams to work tirelessly on it. ”
DR. Toam Katz (Medical Director, Aier Ophthalmology Germany) "In Germany,
Universities (schools) will subsidize some of the patients who are underfunded by their lack of funds.
However, in the case of refractive error surgery, compensation is not given,
Therefore, surgery for refractive error (myopia, farsightedness, etc.) is usually performed in private hospitals.
Academic and discipline development is mainly carried out within the German university system.
It is difficult for private or private institutions to carry out.
Therefore, Aier Eye Hospital Group can focus on the future and build an academic discipline platform.
It's very strategic. ”
Lin Ding (Doctoral Supervisor, Aier School of Ophthalmology, Central South University) "From public to private,
From colleagues in ophthalmology to Aier ophthalmology, I have always insisted on doing academic and research.
With the development of Aier Ophthalmology, the establishment of Aier Academy of Ophthalmology,
I also became a doctoral supervisor at the Aier School of Ophthalmology at Central South University
It has embarked on the development path of integration of medical education and research. ”
Sun Xinghuai (chairman-elect of the Ophthalmology Branch of the Chinese Medical Association) "Now the number of non-public medical institutions has far exceeded the number of public medical institutions.
Rapid development has become a force to be reckoned with.
Aier Eye Hospital Group put forward the issue of "medical education and research system construction".
How can we think strategically and then take it to the next level? How to develop China's national brand,
Give full play to the ability of independent innovation to promote the development of ophthalmology in China? With the help of rich clinical resources, Aier Ophthalmology
It will make remarkable achievements in the field of scientific research and academics. ”
Wang Ningli (former chairman of the Ophthalmology Branch of the Chinese Medical Association) "I think Aier Ophthalmology is a public hospital.
Not a private hospital.
The biggest bottleneck encountered by non-public hospitals is the talent bottleneck, and multi-site practice and talent sharing provide a solution to this bottleneck.
Aier Ophthalmology is a pioneer in the development of non-public hospitals, and its establishment and growth have brought competition and crisis to public eye hospitals.
It will promote the development of medical and ophthalmology in China. ”
Chen Bang (Chairman of Aier Eye Hospital Group) "Aier Ophthalmology is creating a new species! We will "bring in" the excellent technology and experience of the United States, Europe and other worlds, and we will take the strengths of public hospitals and other non-public hospitals.
Make up for the shortcomings of Aier, and truly realize the sharing of global ophthalmic wisdom and the global sharing of Chinese ophthalmic wisdom. ”
In addition, the experts also have high hopes for the future development of Aier Ophthalmology.
They all liked it and sent messages
Suggestions! Professor Sun Xinghuai:
concentrate Aier advantage,
Build a higher platform to innovate and lead ophthalmology.
DR. Toam Katz：
Focus on the sharing of medical resources.
Professor Wang Ningli:
Build a platform, gather popularity, restore light, and create brilliance.
Professor Pang Chi-pui:
Start with the patient and return to the patient.
Professor Wang Mingxu:
Keeping pace with the world and connecting with the frontier,
Enhance the rich content of software.
Professor Lin Ding:
Forge ahead and create brilliance together.
Mr. Chen Bang:
We ophthalmologists should not live up to this wonderful time.
"We are on the way to explore, the curtain has been opened, the giant ship has set sail,
Aier Ophthalmology must not forget its original intention and forge ahead. ”
In the applause of the audience, Professor Tang Shibo gave a speech of thanks.
How to protect your eyes.